Cefamandole: Difference between revisions
m (Protected "Cefamandole": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| Line 26: | Line 26: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Cefamandole''' ([[International Nonproprietary Name|INN]], also known as '''cephamandole''') is a [[broad-spectrum antibiotic|broad-spectrum]] [[cephalosporin]] [[antibiotic]]. The clinically used form of cefamandole is the [[formate]] [[ester]] '''cefamandole nafate''', a [[prodrug]] which is administered [[wikt:parenteral|parenterally]]. | '''Cefamandole''' ([[International Nonproprietary Name|INN]], also known as '''cephamandole''') is a [[broad-spectrum antibiotic|broad-spectrum]] [[cephalosporin]] [[antibiotic]]. The clinically used form of cefamandole is the [[formate]] [[ester]] '''cefamandole nafate''', a [[prodrug]] which is administered [[wikt:parenteral|parenterally]]. | ||
| Line 35: | Line 35: | ||
[[Category:Cephalosporin antibiotics]] | [[Category:Cephalosporin antibiotics]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WS}} | {{WS}} | ||
Revision as of 23:35, 8 August 2012
| File:Cefamandole.svg | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Intramuscular, intravenous |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Protein binding | 75% |
| Elimination half-life | 48 minutes |
| Excretion | Mostly renal, as unchanged drug |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H18N6O5S2 |
| Molar mass | 462.505 g/mol |
|
WikiDoc Resources for Cefamandole |
|
Articles |
|---|
|
Most recent articles on Cefamandole Most cited articles on Cefamandole |
|
Media |
|
Powerpoint slides on Cefamandole |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Cefamandole at Clinical Trials.gov Clinical Trials on Cefamandole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cefamandole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cefamandole Discussion groups on Cefamandole Patient Handouts on Cefamandole Directions to Hospitals Treating Cefamandole Risk calculators and risk factors for Cefamandole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cefamandole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Cefamandole (INN, also known as cephamandole) is a broad-spectrum cephalosporin antibiotic. The clinically used form of cefamandole is the formate ester cefamandole nafate, a prodrug which is administered parenterally.
Cefamandole is no longer available in the United States.
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Cephalosporin antibiotics